4.4 Article

Identification of a Novel de Novo p.Phe932lle KCNT1 Mutation in a Patient With Leukoencephalopathy and Severe Epilepsy

Journal

PEDIATRIC NEUROLOGY
Volume 50, Issue 1, Pages 112-114

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pediatrneurol.2013.06.024

Keywords

leukoencephalopathy; myoclonic; KCNT1; delayed myelination

Funding

  1. National Institutes of Health, National Institute of Neurological Disorders and Stroke [1K08NS060695]
  2. Myelin Disorders Bioregistry Project
  3. ARC Discovery Early Career Research Award
  4. Institute for Molecular Bioscience core funds
  5. University of Queensland Foundation Research Excellence Award
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BACKGROUND: More than half of patients with genetic leukoencephalopathies remain without a specific diagnosis; this is particularly true in individuals with a likely primary neuronal etiology, such as those in which abnormal white matter occurs in combination with severe epilepsy. PATIENT: A child with a severe early infantile epileptic encephalopathy and abnormal myelination underwent whole exome sequencing. RESULTS: Whole exome sequencing identified a heterozygous de novo mutation in KCNT1, a sodium-gated potassium channel gene. CONCLUSIONS: Severely delayed myelination was anecdotally reported in previous patients with KCNT1 mutations. This case reinforces that KCNT1 sequencing should be included in an investigation of patients with severely delayed myelination and epilepsy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available